EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ReRNet: A Deep Learning Network for Classifying Blood Cells

Ziquan Zhu, Shui-Hua Wang, Yu-Dong Zhang iD

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231165856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Ziquan Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Computing and Mathematical Sciences, 4488University of Leicester, Leicester, UK. Hauptthemen laut MEDLINE: Deep Learning. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, British Heart Foundation, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Blood cell classification helps detect various diseases. However, the current classification model of blood cells cannot always get great results. A network that automatically classifies blood cells can provide doctors with data as one of the criteria for diagnosing patients’ disease types and severity. If doctors diagnose blood cells, doctors could spend lots of time on the diagnosis. The diagnosis progress is very tedious. Doctors can make some mistakes when they feel tired. On the other hand, different doctors may have different points on the same patient.

Methods

We propose a ResNet50-based ensemble of randomized neural networks (ReRNet) for blood cell classification. ResNet50 is used as the backbone model for feature extraction. The extracted features are fed to 3 randomized neural networks (RNNs): Schmidt neural network, extreme learning machine, and dRVFL. The outputs of the ReRNet are the ensemble of these 3 RNNs based on the majority voting mechanism. The 5 × 5-fold cross-validation is applied to validate the proposed network.

Results

The average-accuracy, average-sensitivity, average-precision, and average-F1-score are 99.97%, 99.96%, 99.98%, and 99.97%, respectively.

Conclusions

The ReRNet is compared with 4 state-of-the-art methods and achieves the best classification performance. The ReRNet is an effective method for blood cell classification based on these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningHumansNeural Networks, ComputerBlood Cells

Stichwörter der Autor:innen

ResNet50blood cellsconvolutional neural networkrandomized neural network

Autor:innen und Institutionen

  • School of Computing and Mathematical Sciences, 4488University of Leicester, Leicester, UK.
  • School of Computer Science and Technology, Henan Polytechnic University, Jiaozuo, P R China.
  • Department of Information Systems, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Yu-Dong Zhang

Förderung

  • Medical Research Council
  • British Heart Foundation
  • Biotechnology and Biological Sciences Research Council
  • Hope Foundation for Cancer Research
  • Medical Research Council Confidence in Concept Award
  • British Heart Foundation Accelerator Award

Zitieren

APA

Zhu, Z., Wang, S. H., & Zhang, Y. D. (2023). ReRNet: A Deep Learning Network for Classifying Blood Cells. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231165856

Vancouver

Zhu Z, Wang SH, Zhang YD. ReRNet: A Deep Learning Network for Classifying Blood Cells. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231165856

BibTeX
@article{Zhu2023,
  author = {Zhu, Ziquan and Wang, Shui-Hua and Zhang, Yu-Dong},
  title = {ReRNet: A Deep Learning Network for Classifying Blood Cells},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231165856}
}
Kostenlos starten →